Drug Shortage Report for THIAMIJECT INJECTION - LIQ IM IV 100MG/ML
Report ID | 92784 |
Drug Identification Number | 02193221 |
Brand name | THIAMIJECT INJECTION - LIQ IM IV 100MG/ML |
Common or Proper name | Thiamiject® |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | THIAMINE HYDROCHLORIDE |
Strength(s) | 100MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 5 x 10mL vial / fiole |
ATC code | A11DA |
ATC description | VIT B1,PLAIN AND IN COMB WITH VITAMIN B6 AND B12 |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-08-30 |
Estimated end date | 2019-09-30 |
Actual end date | 2019-09-27 |
Shortage status | Resolved |
Updated date | 2019-10-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2019-10-04 | French | Compare |
v4 | 2019-10-04 | English | Compare |
v3 | 2019-08-31 | English | Compare |
v2 | 2019-08-30 | French | Compare |
v1 | 2019-08-30 | English | Compare |
Showing 1 to 5 of 5